TABLE 1.
miRNA | Cell/tissue | Binding site | Function | References |
miR-17 | Cardiomyocyte, H9C2, 293T | 1351−1357 | Hypertrophy↑, Proliferation↑, survival↑; TIMP3 ↓ | Shi et al., 2017; Liu et al., 2018 |
Prostate cancer cells, Bladder cancer cells | 101−123, 524−545 | Proliferation ↑, Survival ↑, migration ↑, invasion ↑, colony formation ↑, tumorigenesis ↑; TIMP3 ↓ | Yang X. et al., 2013; Peng and Li, 2019 | |
miR-21 | HUVECs | 1032−1039 | Survival ↑, migration ↑, capillary formation ↑; TIMP3 ↓, MMP2 ↑, MMP9 ↑ | Hu et al., 2016 |
RCC cell, 293T,cervical cancer cell | 1032−1039 | Proliferation ↑, migration ↑, invasion ↑; TIMP3 ↓ | Chen et al., 2017; Zhang Z. et al., 2018 | |
Podocytes, 293T | 2322−2329 | Apoptosis ↑, IL-1β↑, TNF-α↑, Bax ↑; TIMP3 ↓ | Chen X. et al., 2018 | |
miR-34b | MRC-5, 293T | 1282−1288 | Fibrosis ↑, col I ↑; TIMP3 ↓ | Hu et al., 2019 |
miR-136 | Neuronal cell | 2582−2600 | Apoptosis ↓; TIMP3 ↓ | Jin et al., 2017 |
miR-142 | DRG neuron cells, 293T | 55−61 | Viability ↑, apoptosis ↓; TIMP3 ↓ | Wu et al., 2018 |
miR-181b | Cardiomyocytes, 293T | 797−811 | Apoptosis ↓; TIMP3 ↓ | Gao et al., 2017 |
HCC | 3499−3505, 3573−3580 | Growth ↑, clonogenic survival ↑, migration ↑, invasion ↑, tumorigenicity ↑; TIMP3 ↓, MMP2 ↑, MMP9 ↑ | Wang et al., 2010 | |
miR-191 | Prostate cancer cell | 3553−3573 | Growth ↑, invasion ↑; TIMP3 ↓ | Wang X. et al., 2018 |
miR-205 (miR-712) | iMAECs, VSMCs | 3495−3500 | AAA ↑, inflammation ↑, atherosclerosis ↑, VSMC migration ↑, EC permeability ↑; TIMP3 ↓, RECK ↓, MMP activity ↑, ADAM activity ↑, ADAMTS4 activity ↑ | Son et al., 2013; Kim et al., 2014 |
miR-206 | THP-1, CFb, 293T | 1135−1146, 1683−1689 | Inflammatory cytokines ↑; TIMP3 ↓, MMP2 ↑, MMP9 ↑ | Limana et al., 2011; Fu et al., 2016 |
miR-221 | PTC cell, 293T | 2429−2450 | Proliferation ↑, apoptosis ↓, migration ↑; TIMP3 ↓ | Diao et al., 2017 |
miR-222 | PASMCs, NSCLC, HCC, OS | 2443−2449 | Migration ↑, proliferation ↑, invasion ↑; TIMP3 ↓ | Garofalo et al., 2009; Xu et al., 2017; Guo et al., 2018 |
miR-323a | CFb, 293T | 3590−3596 | Proliferation ↑, fibrosis ↑, Col I ↑, col III ↑, TGF-β↑; MMP2 ↑, MMP9 ↑, TIMP3 ↓ | Zhang J. et al., 2018 |
miR-365 | rMC-1, 293T | 336−342 | Gliosis ↑, oxidative stress ↑; TIMP3 ↓ | Wang J. et al., 2018 |
miR-373 | ESCC cell lines | 112−118 | Migration ↑, proliferation ↑, invasion ↑; TIMP3 ↓ | Liu et al., 2016 |
miR-770 | Podocytes | 227−232 | Apoptosis ↑, IL-1β↑, TNF-α↑; TIMP3 ↓ | Wang and Li, 2020 |
293T, human embryonic kidney 293T cell; AAA, abdominal aortic aneurysm; CFb, cardiac fibroblasts; col, collagen; DRG, dorsal root ganglion; ESCC, Esophageal squamous cell carcinoma; H9C2, rat heart myoblast H9C2 cells; HCC, hepatocellular carcinoma cells; HUVECs, human umbilical vein endothelial cells; iMAECs, immortalized mouse aortic endothelial cells; MRC5, human lung fibroblast line; NSCLC, non-small cell lung cancer cells; OS, osteosarcoma cell; PASMCs, pulmonary artery smooth muscle cells; PTC, papillary thyroid cancer; RCC cell, renal cell cancer cell; RECK, reversion-inducing cysteine-rich protein with kazal motifs; rMC-1, rat Müller cell line; THP-1, human THP-1 macrophages; VSMCs, vascular smooth muscle cells. ↑, increased or activated; ↓, decreased or inactivated.